Interesting find by baggo-mh on the German board;

Interesting find by baggo-mh on the German board; seems like FDA is well aware of the problem of the cytokine storm and open for solutions... this bodes well for CytoDyn:

Healthcare
CytoSorbents' EBP device wins emergency OK to treat COVID-19 patients
Apr. 11, 2020 1:03 PMCytosorbents Corporation (CTSO)By: Carl Surran, SA News Editor
The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent's (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.

Based on bench performance testing and reported clinical experience, the FDA concludes the CytoSorb device - also referred to as an Extracorporeal Blood Purification device - may be effective at treating certain patients with confirmed Covid-19 by removing various pro-inflammatory cytokines from their blood.

The FDA believes the removal of pro-inflammatory cytokines may ameliorate cytokine storm due to the overabundance of pro-inflammatory cytokines and thus provide clinical benefit.


https://www.google.com/amp/s/seekingalpha.com...9-patients